Leishmania cysteine proteinases: From gene to subunit vaccine

Current Genomics

Volumn 4, Issue 3, 2003, Pages 253-261

  Rafati, S ^a   Fasel, N ^b   Masina, S ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIMONY DERIVATIVE; CYSTEINE PROTEINASE; DNA VACCINE; GLYCOPROTEIN; GLYCOPROTEIN GP63; LACK PROTEIN; LEISHMANIA VACCINE; PARASITE ANTIGEN; PLASMID DNA; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TARGETING; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE ISOLATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC SUSCEPTIBILITY; HUMAN; LEISHMANIA; LEISHMANIA MAJOR; LEISHMANIASIS; NONHUMAN; PARASITE VIRULENCE; REVIEW; STRAIN DIFFERENCE; TRYPANOSOMA; VACCINATION;

LEISHMANIA MAJOR; PROTOZOA; TRYPANOSOMA;

EID: 0037377469     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389202033490439     Document Type: Review

References (70)

1. Desjeux, P., Herwaldt, B. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 1996, 14: 417-423.
2. Herwaldt, B. Leishmaniasis. Lancet, 1999, 354: 1191-1199.
3. Solbach, W., Laskay, T. The host response to Leishmania infection. Adv. Immunol. 2000,74:275-317.
4. Desjeux, P. UN AIDS: Leishmania and HIV in Gridlock., Geneva WHO and the UN AIDs, WHO/CTD/LEISH/98 1998, Add. 1 and UNAIDs/98, 23.
5. Albrecht, H. Redefining AIDS: towards a modification of the current AIDS case definition. Clin. Infect. Dis. 1997, 24: 64-74.
6. Myler, P., Stuart, K. Recent developments from the Leishmania genome project. Curr. Opin. Microbiol. 2000, 3: 412-416.
7. Wincker, P., Ravel, C., Blaineau, C., Pages, M., Jauffret, Y., Dedet, J.P., Bastien, P. The Leishmania genome comprises 36 chromosomes conserved across widely divergent human pathogenic species. Nucleic Acids Research, 1996, 24:1688-1694.
8. Graham, S.V., Barry, J.D. Transcriptional regulation of metacyclic variant surface glycoprotein gene expression during the life cycle of Trypanosoma brucei. Mol. Cell Biol. 1995,15: 5945-5956.
9. Pays, E., Vanhamme, L. in ed. Developmental regulation of gene expression in African trypanosomes. (Smith, D. F. a. P., M., Oxford, UK) 1996, 88-114.
10. Ullu, E., Tschudi, C., Günzl, A. in ed. Trans-splicing in trypanosomatid protozoa. (Smith, D. F. a. P., M., Oxford, UK) 1996, 115-133.
11. Mair, G., Shi, H., Li, H., Djikeng, A., Aviles, H., Bishop, J., Falcone, F. Gavrilescu, C., Montgomery, J., Santori, M., Stern, L., Wang, Z., Ullu, E., Tschudi, C. A new twist in trypanosome RNA metabolism: cis-splicing of pre-mRNA. RNA, 2000, 6: 163-169.
12. Myler, P., Audleman, L., deVos, T., Hixson, G., Kiser, P., Lemley, C., Magness, C., Rickel, E., Sisk, E., Sunkin, S., Swartzell, S., Westlake, T., Bastien, P., Fu, G., Ivens, A., Stuart, K. Leishmania major Friedlin chromosome 1 has an unusual distribution of protein-coding genes. Proc. Natl. Acad. Sci. U.S.A. 1999, 96: 2902-2906.
13. Bringaud, F., Vedrenne, C., Cuvillier, A., Parzy, D., Baltz, D., Tetaud, E., Pays, E., Venegas, J., Merlin, G., Baltz, T. Conserved organization of genes in trypanosomatids. Mol. Biochem. Parasitol. 1998, 94: 249-264.
14. Ashford, R., Myler, P., Venkataraman, G., Lodes, M., Stuart, K., Pays, E., Venegas, J., Merlin, G., Baltz, T. Cutaneous leishmaniasis: strategies for prevention. Clin. Dermatol. 1999, 17: 327-332.
15. Croft, S. Monitoring drug resistance in leishmaniasis. Trop. Med. Int. Health, 2001, 6: 899-905.
16. Handman, E. Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev. 2001, 14: 229-243.
17. McMahon-Pratt, D., Kima, P.E., Soong, L. Leishmania Amastigote Target Antigens: The Challenge of a Stealthy Intracellular Parasite. Parasitol. Today, 1998, 14: 31-34.
18. Stager, S., Smith, D., Kaye, P. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J. Immunol. 2000,165: 7064-7071.
19. Solioz, N., Blum-Tirouvanziam, U., Jacquet, R., Rafati, S., Corradin, G., Mauel, J., Fasel, N. The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis. Vaccine, 1999, 18: 850-859.
20. Rappuoli, R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine, 2001, 19: 2688-2691.
21. Pizza, M., Scarlato, V., Masignani, V., Giuliani, M.M., Arico, B., Comanducci, M., Jennings, G.T., Baldi, L., Bartolini, E., Capecchi, B., Galeotti, C.L., Luzzi, E., Manetti, R., Marchetti, E., Mora, M., Nuti, S., Ratti, G., Santini, L., Savino, S., Scarselli, M., Storni, E., Zuo, P., Broeker, M., Hundt, E., Knapp, B., Blair, E., Mason, T., Tettelin, H., Hood, D.W., Jeffries, A.C., Saunders, N.J., Granoff, D.M., Venter, J.C., Moxon, E.R., Grandi, G., Rappuoli, R. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science, 2000, 287: 1816-820.
22. Leitner, W., Ying, H., Restifo, N. DNA and RNA-based vaccines: Principles, progress and prospects. Vaccine, 2000, 18: 765-777.
23. Gurunathan, S., Wu, C., Freidag, B., Seder, R. DNA vaccines: a key for inducing long-term cellular immunity. Curr. Opin. Immunol. 2000, 12: 442-447.
24. Xu, D., Liew, F. Genetic vaccination against leishmaniasis. Vaccine, 1994, 12: 1534-1536.
25. Gurunathan, S., Sacks, D., Brown, D., Reiner, S., Charest, H., Glaichenhaus, N., Seder, R. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 1997, 186: 1137-1147.
26. Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G., Rocken, M., Wagner, H., Heeg, K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 1998, 160: 3627-3630.
27. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., Akira, S. A Toll-like receptor recognizes bacterial DNA. Nature, 2000, 408: 740-745.
28. Medzhitov, R. CpG DNA: security code for host defense. Nat. Immunol. 2001, 2: 15-16.
29. Melby, P., Ogden, G., Flores, H., Zhao, W., Geldmacher, C., Biediger, N., Ahuja, S., Uranga, J., Melendez, M. Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library. Infect. Immun. 2000, 68: 5595-602.
30. Mendez, S., Gurunathan, S., Kamhawi, S., Belkaid, Y., Moga, M., Skeiky, Y., Campos-Neto, A., Reed, S., Seder, R., Sacks, D. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J. Immunol. 2001, 5122-5128.
31. Barrett, A., Buttle, D., Mason, R. Lysosomal cysteine proteinases. ISI Atlas of Sciences and Biochemistry, 1988, 1: 256-2560.
32. Berti, P., Storer, A. Alignment/phylogeny of the papain superfamily of cysteine proteases. J. Mol. Biol. 1995, 246: 273-283.
33. Keyszer, G., Heer, A., Kriegsmann, J., Geiler, T., Trabandt, A., Keysser, M., Gay, R., Gay, S. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum. 1995, 38: 976-984.
34. Paton, J., Andrew, P., Boulnois, G., Mitchell, T. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu. Rev. Microbiol. 1993, 47: 89-115.
35. Pavloff, N., Pemberton, P., Potempa, J., Chen, W., Pike, R., Prochazka, V., Kiefer, M., Travis, J., Barr, P. Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases. J. Biol. Chem. 1997, 272: 1595-1600.
36. Nixon, R. Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesis. Ann. N. Y. Acad. Sci. U.S.A. 1989, 568: 198-208.
37. Chauhan, S., Goldstein, L., Gottesman, M. Expression of cathepsin L in human tumors. Cancer. Res. 1991, 51: 1478-1481.
38. Stoka, V., Turk, B., Schendel, S., Kim, T., Cirman, T., Snipas, S., Ellerby, L., Bredesen, D., Freeze, H., Abrahamson, M., Bromme, D., Krajewski, S., Reed, J., Yin, X., Turk V., Salvesen, G. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J. Biol. Chem. 2001, 276: 3149-3157.
39. Rosenthal, P. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp. Parasitol. 1995, 80: 272-281.
40. Provenzano, D., Alderete, J. Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis. Infect. Immun. 1995, 63: 3388-3395.
41. Keene, W., Hidalgo, M., Orozco, E., McKerrow, J., Provenzano, D., Alderete, J. Entamoeba histolytica: correlation of the cytopathic effect of virulent trophozoites with secretion of a cysteine proteinase. Exp. Parasitol. 1990, 71: 199-206.
42. Nesterenko, M., Tilley, M., Upton, S. A metallo-dependent cysteine proteinase of Cryptosporidium parvum associated with the surface of sporozoites. Microbios. 1995, 83: 77-88.
43. Michalski, W., Crooks, J., Prowse, S. Purification and characterisation of a serine-type protease from Eimeria tenella oocysts. Int. J. Parasitol. 1994, 24: 189-195.
44. Choi, W., Nam, H., Youn, J. Characterization of proteases of Toxoplasma gondii. Kisaengchunghak Chapchi, 1989, 27: 161-170.
45. Aldape, K., Huizinga, H., Bouvier, J., McKerrow, J. Naegleria fowleri: characterization of a secreted histolytic cysteine protease. Exp. Parasitol. 1994, 78:230-241.
46. McKerrow, J., Engel, J., Caffrey, C. Cysteine protease inhibitors as chemotherapy for parasitic infections. Bioorg. Med. Chem. 1999, 7: 639-644
47. Coombs, G. Proteinases of Leishmania mexicana and other flagellate protozoa. Parasitology, 1982, 84: 149-55.
48. Pupkis, M., Tetley, L., Coombs, G. Leishmania mexicana: amastigote hydrolases in unusual lysosomes. Exp. Parasitol. 1986, 62: 29-39.
49. McMahon-Pratt, D., Jaffe, C., Kahl, L., Langer, P., Lohman, K., Pan, A., Rivas, L. 1987 in ed. Characterisation of developmentally regulated molecules of Leishmania. (Chang, K., and Snary, D., Berlin).
50. Rafati, S., Couty-Jouve, S., Alimohammadian, M., Louis, J.A. Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis. Clin. Exp. Immunol. 1997, 110: 203-211.
51. Mottram, J.C., North, M.J., Barry, J.D., Coombs, G.H. A cysteine proteinase cDNA from Trypanosoma brucei predicts an enzyme with an unusual C-terminal extension FEBS Letters, 1989, 258: 211-215.
52. Traub-Cseko, Y., Duboise, M., Boukai, L., McMahon-Pratt, D. Identification of two distinct cysteine proteinase genes of Leishmania pifanoi axenic amastigotes using the polymerase chain reaction. Mol. Biochem. Parasitol. 1993, 57: 101-115.
53. Alves, C., Corte-Real, S., De-Freitas, R.M., Giovanni-DeSimone, S. Detection of cysteine-proteinases in Leishmania amazonensis promastigotes using a cross-reactive antiserum. FEMS Microbiol. Lett. 2000, 186: 263-267.
54. Sakanari, J.A., Nadler, S.A., Chan, V.J., Engel, J.C., Leptak, C., Bouvier, J. Leishmania major: comparison of the cathepsin L- and B-like cysteine protease genes with those of other trypanosomatids. Exp. Parasitol. 1997, 85: 63-76.
55. Cazzulo, J., Couso, R., Raimondi, A., Wernstedt, C., Hellman, U. Further characterization and partial amino acid sequence of a cysteine proteinase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 1989, 33:33-41.
56. Souza, A., Waugh, S., Coombs, G., Mottram, J.C. Characterization of a multi-copy gene for a major stage-specific cysteine proteinase of Leishmania mexicana, FEBS Lett. 1992, 311: 124-127.
57. Huete-Perez, J., Engel, J., Brinen, L., Mottram, J.C., McKerrow, J. Protease trafficking in two primitive eukaryotes is mediated by a prodomain protein motif. J. Biol. Chem. 1999, 274: 16249-16256.
58. Sanderson, S., Pollock, K., Hilley, J., Meldal, M., Hilaire, P., Juliano, M., Juliano, L., Mottram, J.C., Coombs, G. Expression and characterization of a recombinant cysteine proteinase of Leishmania mexicana. Biochem. J. 2000, 347: 383-388.
59. Brooks, D., Tetley, L., Coombs, G., Mottram, J.C. Processing and trafficking of cysteine proteases in Leishmania mexicana. J. Cell. Sci. 2000, 113: 4035-4041.
60. Coombs, G., Mottram, J.C. Parasite proteinases and amino acid metabolism: possibilities for chemotherapeutic exploitation. Parasitology 1997, 114: S61-80
61. Mottram, J.C., Robertson, C.D., Coombs, G.H., Barry, J.D. A developmentally regulated cysteine proteinase gene of Leishmania mexicana. Mol. Microbiol. 1992, 6: 1925-1932.
62. Rafati, S., Salmanian, A., Hashemi, K., Schaff, C., Belli, S., Fasel, N. Identification of Leishmania major cysteine proteinases as targets of the immune response in humans. Mol. Biochem. Parasitol. 2001, 113: 35-43.
63. Omara-Opyene, A.L., Gedamu, L. Molecular cloning, characterization and overexpression of two distinct cysteine protease cDNAs from Leishmania donovani chagasi, Mol. Biochem. Parasitol. 1997, 90: 247-267.
64. Bart, G., Coombs, G.H., Mottram, J.C. Isolation of lmcpc, a gene encoding a Leishmania mexicana cathepsin-B-like cysteine proteinase. Molecular & Biochemical Parasitology, 1995, 73: 271-274.
65. Chan, V., Selzer, P., McKerrow, J., Sakanari, J. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease. Biochem. J. 1999, 340: 113-117.
66. Beyrodt, C.G., Pinto, A.R., Freymuller, E., Barbieri, C.L. Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model. Infect. Immun. 1997, 65: 2052-2059.
67. Rafati, S., Baba, A.A., Bakhshayesh, M., Vafa, M. Vaccination of BALB/c mice with Leishmania major amastigote-specific cysteine proteinase. Clin. Exp. Immunol. 2000, 120: 34-38.
68. Wolfram, M., Ilg, T., Mottram, J.C., Overath, P. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites. Eur. J. Immunol. 1995, 25: 1094-1100.
69. + T lymphocyte activation. Vaccine, 2002, 20: 2439-2447.
70. Rafati, S., Salmanian, A., Taheri, T., Vafa, M., Fasel, N. A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major. Vaccine, 2001, 19: 3369-3375.